Emerald Health Oversubscribed Offering to Finance Expansion


Ryan Allway

April 26th, 2017

News, Top News


Canada’s cannabis industry could surpass $22 billion in size over the coming years, surpassing the country’s wine and spirits industry in size. While there are about 40 licensed producers, many of these companies have already achieved lofty valuations in anticipation of the growing market. The good news is that there are a handful of companies that remain relatively undervalued with plans to significantly grow their footprint.

In this article, we will take a look at Emerald Health Therapeutics Inc.’s (TSX-V: EMH) public offering and its progress in expanding its operations.

Significant Investor Interest

Emerald Health began its public offering on April 10 and ended up issuing 13,170,000 units at $1.85 each for gross proceeds of $24,364,500. The day following the initial closing, the company announced the closing of an over-allotment, adding another $2,758,923 in gross proceeds to the deal.

The units sold in the public offering consist share of common stock and one-half of a common share purchase warrant. The warrant enables the holder to acquire one share of common stock at a price of $2.60 per share for a 24 month period after the offering. If the company’s stock exceeds $3.50 per share for 20 consecutive trading days, the company may accelerate the expiration date to the 30th day after notice is given.

Emerald Health shares trade at $1.28 each right now, which is below the $1.85 unit price and the $2.60 per share exercise price. In other words, investors can purchase the stock in the open market with 100% upside before the warrants start to trigger while benefiting from the $27 million in capital to expand its footprint in the industry. The company’s modest ~$120 million market capitalization (factoring in all shares issued post financing) is also attractive relative to many other licensed producers.

Ambitious Expansion Plans

Canada’s cannabis industry is expected to reach upwards of $22 billion over the coming years, according to Deloitte Canada, driven by the legalization of recreational use. The analyst projects that $8.7 billion will come from the plant’s retail market while ancillary products and services – like growers, testing labs, lighting, and security equipment – will bring in the rest. This market could make the cannabis industry rival the country’s wine and spirits industry in size.

Emerald Health plans to build out its presence in 50,000 square foot expansions based on demand. Initially, the company plans to expand its footprint to 100,000 square feet in 2017 and generate about 10,000 kilograms of dried cannabis per year. Its 32-acre property means that it can continue to expand its presence with up to a million square feet of growing space capable of producing upwards of 100,000 kilograms per year of dried cannabis.

In addition to its production capacity, the company continues to differentiate its products with a very large and diverse library of strains and products that are backed by actual clinical studies. The company’s facilities also grow, extract, and process cannabis to pharmaceutical grade standards, while keeping costs low enough to be very competitively priced. Management’s experience in life sciences and genetics underscores their commitment to quality.

Looking Ahead

Emerald Health Therapeutics Inc. (TSX-V: EMH) trades with a market capitalization of just $100 million compared to an average of over $500 million for the five largest licensed producers in the space. With nearly $25 million in fresh capital, the company is well-positioned to execute on its ambitious plans to expand to 100,000 square feet this year and produce upwards of 10,000 kilograms of cannabis for sale as dried product or cannabis oils.

The company’s recent inclusion in the first cannabis exchange-traded fund (ETF) – Horizons Medical Marijuana Life Sceinces ETF (TSE: HMMJ) – the stock could further benefit from buying if the fund draws significant assets. Currently, the ETF holds a 2.31% stake in Emerald Health among its 14 stocks targeting the global cannabis industry, which is also a testament to the company’s growing presence in the industry.

For more information, visit the company’s website, investor presentation, or CannabisFN company profile.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading